Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: Prev Med. 2016 Mar 20;88:20–26. doi: 10.1016/j.ypmed.2016.03.016

Table 2.

Association between sources of protein intake and gallbladder disease using Cox proportional hazards regression

Protein source n events (%) Model 1a
HR (95% CI)
Model 2b
HR (95% CI)
Vegetable proteinc
 Quintile 1 2381 (9.1) 1.00 1.00
 Quintile 2 2208 (8.4) 0.95 (0.90–1.01) 0.95 (0.89–1.02)
 Quintile 3 2062 (7.9) 0.88 (0.83–0.94) 0.90 (0.84–0.96)
 Quintile 4 2066 (7.9) 0.88 (0.83–0.93) 0.91 (0.85–0.97)
 Quintile 5 1898 (7.3) 0.79 (0.74–0.84) 0.87 (0.81–0.93)
 Test for trend P < 0.001 P < 0.001
 Continuous 0.86 (0.83–0.89) 0.91 (0.88–0.95)
Animal proteinc
 Quintile 1 2047 (7.8) 1.00 1.00
 Quintile 2 2081 (8.0) 1.05 (0.98–1.11) 1.00 (0.93–1.07)
 Quintile 3 2096 (8.0) 1.06 (1.00–1.13) 1.00 (0.94–1.07)
 Quintile 4 2117 (8.1) 1.06 (1.00–1.13) 0.96 (0.90–1.03)
 Quintile 5 2274 (8.7) 1.12 (1.06–1.19) 1.00 (0.94–1.07)
 Test for trend P < 0.001 P = 0.754
 Continuous 1.02 (1.01–1.04) 0.99 (0.98–1.01)
Total proteinc
 Quintile 1 2142 (8.2) 1.00 1.00
 Quintile 2 2125 (8.1) 1.03 (0.97–1.09) 1.00 (0.94–1.07)
 Quintile 3 2100 (8.0) 1.01 (0.95–1.08) 0.96 (0.90–1.03)
 Quintile 4 2061 (7.9) 0.99 (0.93–1.05) 0.92 (0.86–0.99)
 Quintile 5 2187 (8.4) 1.03 (0.97–1.09) 0.95 (0.89–1.01)
 Test for trend P = 0.718 P = 0.021
 Continuous 1.00 (0.99–1.01) 0.98 (0.97–1.00)
a

Model 1 is adjusted for age and total energy (log-transformed)

b

Model 2 is further adjusted for BMI, physical activity, neighborhood socioeconomic status, race/ethnicity, oral contraceptive use, hormone therapy use, history of liver disease, statin use, thiazide use, alcohol use, and clinical trial arm(s)

c

Energy-adjusted